⏳ Fetching live dividend data...
Home › Calculator › VIAP Dividend Calculator 2026
VIA Pharmaceuticals, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in VIAP → $3.690270327864796e+47M in 10 years · $30,752,245,224,334,260,000,000,000,000,000,000,000,000,000,000,000,000.00/month
VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases. It is developing a pipeline of small molecule drugs that target the underlying causes of cardiovascular and metabolic diseases, including vascular inflammation, high cholesterol, high triglycerides, and insulin sensitization/diabetes. The company's drug development pipeline includes VIA-3196, a Phase-1 ready liver-directed thyroid hormone receptor (THR) beta agonist that targets dyslipidemia, such as high LDL cholesterol, high triglycerides, and elevated Lp(a); Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor, which is in pre-clinical development stage treatment of type 2 diabetes with upside potential in weight control and dyslipidemia; and VIA-2291, a 5-Lipoxygenase inhibitor that has completed third Phase 2 clinical trial for the treatment of atherosclerotic plaque, an underlying cause of heart attack, stroke, and other vascular diseases. VIA Pharmaceuticals, Inc. has two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. for THR beta agonist; and multiple compounds from preclinical DGAT1 metabolic disorders program. The company was founded in 2004 and is headquartered in San Francisco, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open VIAP position with:
Real after-tax yield depends on where you live and how you hold VIAP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 400000.00% | 399997.20% | $40,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 340000.00% | 339997.20% | $34,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 320000.00% | 319997.20% | $32,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 400000.00% | 399997.20% | $40,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 365000.00% | 364997.20% | $36,500,000 / yr |
| 🇨🇦 TFSA | 0% | 400000.00% | 399997.20% | $40,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 300000.00% | 299997.20% | $30,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 340000.00% | 339997.20% | $34,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 280000.00% | 279997.20% | $28,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 294500.00% | 294497.20% | $29,450,000 / yr |
| 🇫🇷 FR Taxable | 30% | 280000.00% | 279997.20% | $28,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
VIAP pays quarterly — 4 times per year. Next ex-div: TBD.
How VIAP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VIAP sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2010-11-15 | 3,671,806 | $0.07 | $260.7K | ||
| Buy | 2010-11-15 | 60,495 | $0.07 | $4.3K | ||
| Other | 2010-04-01 | 40,000 | $2.38 | $95.2K | ||
| Other | 2010-04-01 | 9,300 | $3.48 | $32.4K | ||
| Other | 2010-04-01 | 6,691 | $0.14 | $937.00 | ||
| Buy | 2010-03-26 | 1,533,519 | $0.17 | $260.7K | ||
| Buy | 2010-03-26 | 25,265 | $0.17 | $4.3K | ||
| Buy | 2009-03-12 | 7,241,618 | $0.12 | $869.0K | ||
| Buy | 2009-03-12 | 119,308 | $0.12 | $14.3K | ||
| A-Award | 2008-12-17 | 125,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VIAP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →